Cutler Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,000
| Closed | -$8K | – | 1487 |
|
|
2023
Q2 | $8K | Buy |
+2,000
| New | +$8K | ﹤0.01% | 1012 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1620 |
|
|
2020
Q1 | – | Sell |
-300
| Closed | -$5K | – | 1507 |
|
|
2019
Q4 | $5K | Sell |
300
-1,300
| -81% | -$21.7K | ﹤0.01% | 1317 |
|
|
2019
Q3 | $32K | Buy |
+1,600
| New | +$32K | ﹤0.01% | 940 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1579 |
|
|
2018
Q4 | – | Sell |
-1,800
| Closed | -$29K | – | 1678 |
|
|
2018
Q3 | $29K | Buy |
1,800
+1,700
| +1,700% | +$27.4K | ﹤0.01% | 1079 |
|
|
2018
Q2 | $1K | Sell |
100
-6,600
| -99% | -$66K | ﹤0.01% | 1570 |
|
|
2018
Q1 | $74K | Sell |
6,700
-1,104
| -14% | -$12.2K | 0.01% | 836 |
|
|
2017
Q4 | $68K | Sell |
7,804
-7,668
| -50% | -$66.8K | ﹤0.01% | 988 |
|
|
2017
Q3 | $206K | Buy |
15,472
+1,088
| +8% | +$14.5K | 0.01% | 738 |
|
|
2017
Q2 | $206K | Buy |
14,384
+12,584
| +699% | +$180K | 0.01% | 849 |
|
|
2017
Q1 | $38K | Sell |
1,800
-5,721
| -76% | -$121K | ﹤0.01% | 1612 |
|
|
2016
Q4 | $211K | Buy |
7,521
+3,101
| +70% | +$87K | 0.01% | 825 |
|
|
2016
Q3 | $118K | Buy |
+4,420
| New | +$118K | 0.01% | 1037 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 2865 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 2849 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 2929 |
|